[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:mouse-bi-phenotypic-leukemia":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Mouse Bi-phenotypic Leukemia",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06466395","A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias",[11],"Phase 1","RECRUITING","2026-08-26T02:19:08.862440Z","2026-05-05T02:43:28.289024Z",[],[]]